4.7 Review

Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19

Journal

NANOMEDICINE
Volume 15, Issue 21, Pages 2085-2102

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/nnm-2020-0247

Keywords

chloroquine; coronavirus; COVID-19; nanomedicine; remdesivir; SARS-CoV-2

Ask authors/readers for more resources

The COVID-19 pandemic caused by the newly emerged severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) puts the world in an unprecedented crisis, leaving behind huge human losses and deep socioeconomic damages. Due to the lack of specific treatment against SARS-CoV-2, effective vaccines and antiviral agents are urgently needed to properly restrain the COVID-19 pandemic. Repositioned drugs such as remdesivir have revealed a promising clinical efficacy against COVID-19. Interestingly, nanomedicine as a promising therapeutic approach could effectively help win the battle between coronaviruses (CoVs) and host cells. This review discusses the potential therapeutic approaches, in addition to the contribution of nanomedicine against CoVs in the fields of vaccination, diagnosis and therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available